Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: past medical history: 1. asthma. 2. congestive heart failure. 3. syncope. 4. status post endoscopic retrograde cholangiopancreatography revealing a benign ampullary polyp, status post stent. 5. hypertension. 6. ekg evidence of prior myocardial infarction. 7. previous eye surgery with loss of vision from a prior fall. 8. osteoporosis. 9. borderline diabetes mellitus. allergies: the patient has no known drug allergies. social history: the patient lives in her daughter's home on the . she is a widow. she denies tobacco or alcohol use. family history: mother died at the age of 65 of a myocardial infarction. daughter with diabetes, lung cancer and a brother with disease. medications on admission: 1. atenolol 25 mg p.o.q.d. 2. diovan 160 mg p.o.q.d. 3. singulair 10 mg p.o.q.p.m. 4. fosamax 10 mg p.o.t.i.d. 5. albuterol metered-dose inhaler two puffs q.4-6h.p.r.n. 6. serevent two puffs b.i.d. 7. flovent 2-4 puffs b.i.d. 8. lasix 20 mg p.o.q.d. 9. k-dur 10 meq p.o.q.d. 10. dilantin 300 mg p.o.q.d. physical examination: examination revealed that the patient had a temperature of 95.2; blood pressure 60/30; and immediately after 20 to 30 seconds her blood pressure increased to 110/75. heart rate paced at 100. respiratory rate of 12. the co2 was 86%, which, after oxygen supplementation rose to 94%. heent: examination of the right eye is fixed and dilated. left pupil was reactive. extraocular muscles are intact. mucous membranes are dry. neck was supple, no bruits bilaterally. jugular venous distention to the bottom of the neck at 5 degrees. heart regular rate and rhythm with no murmurs or gallops. lungs revealed bilateral wheezing throughout and rales at the right base. abdomen was soft, nontender and nondistended with positive bowel sounds. extremities: there was 1+ trace edema bilaterally. laboratory data: laboratory studies revealed the white blood cell count of 8.8, hematocrit of 33.7, platelet count 203, pt 1.1; inr 1.1, ptt 21.4; sodium of 138; potassium of 4.5; chloride of 104; bicarbonate of 26; bun of 24; creatinine of .7; glucose 121; calcium of 8.3; phosphate 3.4; magnesium of 1.8. chest x-ray revealed possible upper-zone redistribution. echocardiogram #1: pte #1: ejection fraction of 50-60 posterior hypokinesis, trivial effusion no tamponade. pte #2: ejection fraction to 50%, mild global left ventricular hypokinesis, small effusion, larger than prior echocardiogram noted at the apex. no tamponade. pte #3: trial effusion, no tamponade. hospital course: during her hospital stay, the patient had had several episodes of fleeting hypotension, the first of which was noted upon arrival to the cardiac intensive care unit. during each of these episodes, the patient complained of feeling light headeded. given that she was paced at an elevated rate during these episodes, it was concluded that there was a contributory vasodilatory component to her syncope. the patient was started on lopressor 25 mg b.i.d., which was titrated to 50 mg p.o.b.i.d. the dose was not further advanced given the patient's severe asthma and worsening wheezing noted on the examination. the patient tolerated this medication well. during the course of the hospitalization, the patient had several episodes of rapid atrial fibrillation with a ventricular response rate in the 120s. the maximum tracking rate of the pacemaker was turned down to 120 and the mode switch was set to on. the patient was then started on a loading dose of amiodarone 200 mg p.o. t.i.d. the patient will be taking this for a duration of six weeks. thereafter, the patient will take 400 mg p.o.q.d. baseline thyroid function tests, liver function tests and pulmonary function tests have been obtained. after the initiation of the amiodarone, the patient was not noted to have any further episodes of atrial fibrillation. the patient was not deemed to be a suitable candidate for anticoagulation given her fall and risk. with regards to her syncope, the patient has been referred to dr. of the clinic for a further evaluation of his problem. the patient was evaluated by the department of physical therapy and there was some concern for her safety at home. the patient lives on the of her daughter's home. it was thus decided that the patient would require an inpatient acute rehabilitation stay prior to being sent home. condition on discharge: stable with fall precautions. discharge diagnosis: 1. neurological: cardiogenic syncope. 2. new onset atrial fibrillation. 3. asthma. 4. borderline diabetes. 5. osteoporosis. medications on discharge: 1. dilantin 300 mg p.o.q.d. 2. amiodarone 200 mg t.i.d. for six weeks (starting date ) and then 400 mg p.o.q.d. 3. singulair, fosamax, albuterol, serevent, aspirin, tylenol, lopressor 50 mg p.o.b.i.d., eye drops. follow-up care: the patient will followup with dr. of the autonomic laboratory on , at 1 p.m. the patient will also followup with dr. on , at 1:30 p.m. , m.d. dictated by: medquist36 procedure: initial insertion of dual-chamber device initial insertion of transvenous leads [electrodes] into atrium and ventricle diagnoses: atrial fibrillation other convulsions nausea with vomiting other specified cardiac dysrhythmias syncope and collapse hemopericardium moderate or severe impairment, one eye, impairment level not further specified 

Answer: The patient is high likely exposed to